Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06098118 · ClinicalTrials.gov registry record · NA

Adapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by PFAS

A NA study of Breast Cancer Screening, sponsored by Trustees of Dartmouth College.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06098118 is a NA study of Breast Cancer Screening that has completed, run by Trustees of Dartmouth College. The registered enrollment target is 100 participants, below the 63,430-participant average among 8 other Breast Cancer Screening trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06098118, a NA study of Breast Cancer Screening, has completed, sponsored by Trustees of Dartmouth College.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This community-engaged research project will test an adapted online breast cancer screening decision aid to address the needs of women living in an area where environmental contamination has increased concern about breast cancer risk. It will provide novel data on individual experiences with breast cancer risk assessment and decisional determinants of screening choices in a community disproportionately impacted by industrial pollution.

Conditions Studied

Interventions

  • BEHAVIORAL MyMammogram decision aid

Study Locations (1)

New Hampshire

  • Dartmouth College - Hanover

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-05-06
Est. Completion 2024-12-23
Phase NA

Sponsor

Trustees of Dartmouth College

31 total trials

What the Registry Record Tells You About NCT06098118

The ClinicalTrials.gov registry entry for NCT06098118 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 63,430-participant average among 8 other Breast Cancer Screening trials with a reported enrollment target (100% lower). The listed sponsor is Trustees of Dartmouth College, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which MyMammogram decision aid is the first listed.

NCT06098118 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT06098118 about?

NCT06098118 is a clinical study titled "Adapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by PFAS". This community-engaged research project will test an adapted online breast cancer screening decision aid to address the needs of women living in an area where environmental contamination has increased concern about breast cancer risk. It will provide novel data on individual experiences with breast ...

What is the current status of trial NCT06098118?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2024-05-06. Estimated completion is 2024-12-23.

What conditions does trial NCT06098118 study?

This clinical trial studies the following conditions: Breast Cancer Screening.

What interventions are being tested in trial NCT06098118?

The interventions under investigation include: MyMammogram decision aid (BEHAVIORAL).

Who is sponsoring clinical trial NCT06098118?

This trial is sponsored by Trustees of Dartmouth College, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06098118 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.